UNSPSC 85761626: Control bleeding in respiratory tract, via natural or artificial opening

This classification denotes the group of activities that yields a surgical intervention or procedure to control bleeding in respiratory tract, via natural or artificial opening. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0W3Q7ZZ

UNSPSC 85761626 Control bleeding in respiratory tract, via natural or artificial opening (Commodity) shows minimal recent state and local procurement activity aligned with the code's nominal scope. The six recent opportunities posted to state and local procurement platforms under or near this code are predominantly health services contracting — independent medical evaluations for pension disability determinations, surgical benefit carve-outs, occupational medical surveillance, emergency and specialty care for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which map to hemorrhage control in the respiratory tract or related clinical interventions. The issuing bodies span state health and transportation departments, counties, cities, and local health systems across multiple states and regions, but none of the opportunities reflect procurement of respiratory bleeding-control products, supplies, or clinical services as the code describes.

The geographic spread includes Arizona (City of Phoenix), California (City of Long Beach, County of Santa Clara), Washington (Washington State Department of Transportation), Texas (Harris County), and Florida (Collier County), but this distribution reflects general health services and administrative contracting rather than concentration around the specific clinical domain the code names. No representative recent opportunities exist that match the respiratory hemorrhage-control commodity scope. State and local procurement under this code is either dormant or systematically tagged with misaligned health-services opportunities, making it difficult to assess genuine buying patterns or issuing-body concentration for the intended product or service line.